Inventor · disambiguated record
Sam Butterworth
Also filed as: BUTTERWORTH SAM
6 granted patents·8 pending applications·44 citations·filing 2007–2024
79Inventor score
Top patents by PatentIndex Score
14 records- 0193US8946235B22-(2,4,5-substituted-anilino) pyrimidine compoundsBUTTERWORTH SAM·Filed 2012·Granted Feb 3, 2015·39 cites·12 claims
- 0291US9732058B22-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2014·Granted Aug 15, 2017·5 cites·6 claims
- 0384US2024425476A12-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0482US2024182441A12-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0570US11524951B22-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2020·Granted Dec 13, 2022·0 cites·8 claims
- 0669US10858336B22-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2019·Granted Dec 8, 2020·0 cites·7 claims
- 0765US10017493B22-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2017·Granted Jul 10, 2018·0 cites·14 claims
- 0863US2019092746A12-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 0952US2025154157A1Heterocyclic compounds useful for treating a erk5-mediated diseaseCANCER RESEARCH TECH LTD·Filed 2023·Application pending·0 cites
- 1044US2009270390A1Pyrimidine derivativesASTRAZENECA·Filed 2007·Application pending·0 cites
- 1144US2010022534A12-benzimidazolyl-6-morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disordersASTRAZENECA·Filed 2007·Application pending·0 cites
- 1241US2009233926A12-benzimidazolyl-6-morpholino-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disordersASTRAZENECA·Filed 2007·Application pending·0 cites
- 1338US2009325954A12-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disordersBUTTERWORTH SAM·Filed 2007·Application pending·0 cites
- 1431US11530193B2Kinase inhibitorsUNIV MANCHESTER·Filed 2019·Granted Dec 20, 2022·0 cites·38 claims
Join the waitlist — get patent alerts
Get an alert when Sam Butterworth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →